{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:38:55Z","timestamp":1791581935593,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03182-x","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:01:28Z","timestamp":1719028888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes"],"prefix":"10.1007","volume":"44","author":[{"given":"Komal","family":"Bakal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Molugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaleel","family":"Machakuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya Madhuri","family":"Bejjanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anasua Ganguly","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-9961","authenticated-orcid":false,"given":"Swathi","family":"Kaliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"3182_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","volume":"49","author":"CL Shields","year":"2004","unstructured":"Shields CL, Shields JA (2004) Tumours of the conjunctiva and cornea. Surv Ophthalmol 49:3\u201324","journal-title":"Surv Ophthalmol"},{"key":"3182_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0140-6736(95)90870-6","volume":"345","author":"C Ateenyi-Agaba","year":"1995","unstructured":"Ateenyi-Agaba C (1995) Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala. Uganda The Lancet 345:695\u2013696","journal-title":"Uganda The Lancet"},{"key":"3182_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(96)91685-2","volume":"347","author":"R Newton","year":"1996","unstructured":"Newton R, Ferlay J, Reeves G, Beral V, Parkin DM (1996) Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. The Lancet 347:1450\u20131451","journal-title":"The Lancet"},{"issue":"6","key":"3182_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10792-021-02189-y","volume":"42","author":"S Kaliki","year":"2022","unstructured":"Kaliki S, Vempuluru VS, Ghose N, Gunda S, Vithalani NM, Sultana S et al (2022) Ocular surface squamous neoplasia in India: a study of 438 patients. Int Ophthalmol 42(6):1915\u20131926","journal-title":"Int Ophthalmol"},{"issue":"11","key":"3182_CR5","first-page":"10","volume":"9","author":"PP Dandala","year":"2015","unstructured":"Dandala PP, Malladi P, Kavitha (2015) Ocular surface squamous neoplasia (OSSN) a retrospective study. J Clin Diagn Res 9(11):10\u201313","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"3182_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","volume":"115","author":"JA Shields","year":"1997","unstructured":"Shields JA, Shields CL, De Potter P (1997) Surgical management of conjunctival tumors: the 1994 Lynn B McMahan Lecture. Archives ophthalmol 115(6):808\u2013815","journal-title":"Archives ophthalmol"},{"issue":"3","key":"3182_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0161-6420(97)30287-5","volume":"104","author":"G Tabin","year":"1997","unstructured":"Tabin G, Levin S, Snibson G, Loughnan M, Taylor H (1997) Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104(3):485\u2013492","journal-title":"Ophthalmology"},{"issue":"2","key":"3182_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40123-018-0140-z","volume":"7","author":"MV Cicinelli","year":"2018","unstructured":"Cicinelli MV, Marchese A, Bandello F, Modorati G (2018) Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther 7(2):247\u2013262","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"3182_CR9","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/ICO.0b013e3182a6ea6c","volume":"32","author":"E Adler","year":"2013","unstructured":"Adler E, Turner JR, Stone DU (2013) Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012. Cornea 32(12):1558\u20131561","journal-title":"Cornea"},{"issue":"5","key":"3182_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/APO.0000000000000104","volume":"4","author":"R Kusumesh","year":"2015","unstructured":"Kusumesh R, Ambastha A, Sinha B, Kumar R (2015) Topical interferon alpha-2b as a single therapy for primary ocular surface squamous neoplasia. Asia Pac J Ophthalmol (Phila) 4(5):279\u2013282","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"3182_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1442-6404.2002.00497.x","volume":"30","author":"M Daniell","year":"2002","unstructured":"Daniell M, Maini R, Tole D (2002) Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Exp Ophthalmol 30(2):94\u201398","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"3182_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1586\/eop.13.16","volume":"8","author":"M Tsatsos","year":"2014","unstructured":"Tsatsos M, Karp CL (2014) Modern management of ocular surface squamous neoplasia. Expert Rev Ophthalmol 8(3):287\u2013295","journal-title":"Expert Rev Ophthalmol"},{"issue":"7","key":"3182_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/bjo.2005.086850","volume":"90","author":"JJ Khong","year":"2006","unstructured":"Khong JJ, Muecke J (2006) Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 90(7):819\u2013822","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3182_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40662-019-0150-5","volume":"12","author":"G Al Bayyat","year":"2019","unstructured":"Al Bayyat G, Arreaza-Kaufman D, Venkateswaran N, Galor A, Karp CL (2019) Update on pharmacotherapy for ocular surface squamous neoplasia. Eye Vis (Lond) 12(6):24. https:\/\/doi.org\/10.1186\/s40662-019-0150-5","journal-title":"Eye Vis (Lond)"},{"key":"3182_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"D Longley","year":"2003","unstructured":"Longley D, Harkin D, Johnston P (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330\u2013338","journal-title":"Nat Rev Cancer"},{"key":"3182_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2165\/00003495-200767020-00005","volume":"67","author":"SM Abraham","year":"2007","unstructured":"Abraham SM, Selva D, Casson R, Leibovitch I (2007) The clinical applications in fluorouracil in ophthalmic practice. Drugs 67:237\u2013255","journal-title":"Drugs"},{"issue":"1","key":"3182_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17469899.2017.1263567","volume":"12","author":"IO Sayed-Ahmed","year":"2017","unstructured":"Sayed-Ahmed IO, Palioura S, Galor A, Karp CL (2017) Diagnosis and medical management of ocular surface squamous neoplasia. Expert Rev Ophthalmol 12(1):11\u201319","journal-title":"Expert Rev Ophthalmol"},{"key":"3182_CR18","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.2147\/OPTH.S70459","volume":"8","author":"RJ Nutt","year":"2014","unstructured":"Nutt RJ, Clements JL, Dean WH (2014) Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola. Clin Ophthalmol 8:2435\u20132440","journal-title":"Clin Ophthalmol"},{"key":"3182_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/bjo.84.3.268","volume":"84","author":"E Midena","year":"2000","unstructured":"Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P (2000) Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 84:268\u2013272","journal-title":"Br J Ophthalmol"},{"key":"3182_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtos.2022.12.002","volume":"27","author":"A Wylegala","year":"2023","unstructured":"Wylegala A, Sripawadkul W, Zein M, Alvarez OP, Al Bayyat G, Galor A et al (2023) Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study. Ocul Surf 27:67\u201374","journal-title":"Ocul Surf"},{"issue":"4","key":"3182_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s40123-022-00535-6","volume":"11","author":"W Geng","year":"2022","unstructured":"Geng W, Wang JS, Shi BJ, Xie HT, Zhang MC (2022) Topical chemotherapy for treating ocular surface squamous neoplasia with a combination of interferon \u03b1-2b and 5-Fluorouracil. Ophthalmol Therapy 11(4):1563\u20131576","journal-title":"Ophthalmol Therapy"},{"key":"3182_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjophthalmol-2016-309219","volume":"101","author":"R Parrozzani","year":"2017","unstructured":"Parrozzani R, Frizziero L, Trainiti S, Testi I, Miglionico G, Pilotto E et al (2017) Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol 101:1094\u20131099","journal-title":"Br J Ophthalmol"},{"key":"3182_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0002-9394(14)73072-7","volume":"117","author":"J Frucht-Pery","year":"1994","unstructured":"Frucht-Pery J, Rozenman Y (1994) Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 117:164\u2013168","journal-title":"Am J Ophthalmol"},{"key":"3182_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/00003226-200210000-00017","volume":"21","author":"AA Papandroudis","year":"2002","unstructured":"Papandroudis AA, Dimitrakos SA, Stangos NT (2002) Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia. Cornea 21:715\u2013717","journal-title":"Cornea"},{"key":"3182_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00003226-199709000-00020","volume":"16","author":"SH Tseng","year":"1997","unstructured":"Tseng SH, Tsai YY, Chen FK (1997) Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Cornea 16:595\u2013597","journal-title":"Cornea"},{"key":"3182_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","volume":"115","author":"A Sturges","year":"2008","unstructured":"Sturges A, Butt AL, Lai JE, Chodosh J (2008) Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 115:1297\u20131302","journal-title":"Ophthalmology"},{"key":"3182_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/2008-322X.150811","volume":"9","author":"S Zarei-Ghanavati","year":"2014","unstructured":"Zarei-Ghanavati S, Alizadeh R, Deng SX (2014) Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360 degrees limbal involvement. J Ophthalmic Vis Res 9:423\u2013426","journal-title":"J Ophthalmic Vis Res"},{"key":"3182_CR28","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0161-6420(00)00389-4","volume":"107","author":"RP Yeatts","year":"2000","unstructured":"Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA (2000) 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 107:2190\u20132195","journal-title":"Ophthalmology"},{"key":"3182_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bjo.2010.183244","volume":"95","author":"R Parrozzani","year":"2011","unstructured":"Parrozzani R, Lazzarini D, Alemany-Rubio E, Urban F, Midena E (2011) Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol 95:355\u2013359","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"3182_CR30","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ophtha.2016.02.034","volume":"123","author":"MG Joag","year":"2016","unstructured":"Joag MG, Sise A, Murillo JC, Sayed-Ahmed IO, Wong JR, Mercado C et al (2016) Topical 5-Fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology 123(7):1442\u20131448","journal-title":"Ophthalmology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03182-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:53:10Z","timestamp":1741881190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03182-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03182-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,22]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of LV Prasad Eye Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"251"}}